ELLE editors went on a deep dive to answer all of the most common questions about Ozempic and other similar drugs. Below, ...

HLB Group acquires ANYGEN to boost GLP-1 obesity treatment development HLB Group enhances peptide capabilities through ANYGEN ...

Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

A Stanford Medicine study taps artificial intelligence to find a naturally occurring molecule called a peptide that ...

A Central Illinois cardiologist breaks down the potential benefits of GLP-1 medications on heart health. It was one of the ...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...